Franklin Genomic Advancements Fund N (acc) USD Fonds VALOR 113697895 / ISIN LU2387456168

So investiert der Franklin Genomic Advancements Fund N (acc) USD Fonds: The Fund's investment objective is capital appreciation. The Fund invests principally in equity securities of companies that are relevant to the Fund’s investment theme of genomic advancements. Equity securities generally entitle the holder to participate in a company's general operating results. While the Fund invests predominantly in common stocks, it could also invest in preferred stock, convertible securities and warrants on securities.